CTOO Pedro Cruz Participates in Festival of Biologics 2025

Highlighting Gene Therapy Accessibility and Advanced MS Bioanalytics

Pedro Cruz, CTOO, represented iBET and actively participated in the Festival of Biologics, held in Basel, Switzerland, from September 30 to October 2.

At the event, Pedro Cruz joined a high-profile panel on “The Accessibility of Curative Gene Therapies”, contributing with expert perspectives on strategies to broaden patient access to transformative treatments.

Additionally, Pedro presented a poster titled “Advanced MS Bioanalytics for mAbs: PTM characterization and HCP profiling to optimize process design space”, showcasing iBET’s novel application of mass spectrometry-based Multiple Attribute Method (MAM) technique for comprehensive monoclonal antibody characterization.

The event provided an excellent platform for iBET to demonstrate leadership in advanced bioprocess analytics and foster strategic partnerships within the biologics sector.

Related news

iBET’s Research at ECI Advancing Manufacture of Cell & Gene Therapies IX Conference: Best Poster Award
February 12, 2026

iBET at PEGS Europe 2025: Advancing Biopharmaceuticals’ Development
November 18, 2025

iBET’s Advanced Bioanalytics R&D Presented at Gene and Cell Therapies 2025 in Munich
June 11, 2025

Latest Advancements in Bioanalytics and rAAV Production Presented at BioProcess International Europe 2025
May 21, 2025

iBET at NextGen Biomed 2025: Patricia Alves Presents MS-based Bioanalytics for Efficient DSP Polishing Platform Characterization
March 18, 2025